D-0599-2025 Class II Terminated
FDA drug recall D-0599-2025 was initiated by Lannett Company Inc. on Aug 11, 2025 and is designated Class II. Reason for recall: Labeling: Label Mix-up. A bottle labeled as Lisdexamphetamine Dimesylate Capsules 40mg, contained Lisdexamphetamine Dimesylate Capsules 30mg. The recall status is terminated (terminated Jun 24, 2026). Affected quantity: 8544 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Sep 3, 2025
- Initiation Date
- Aug 11, 2025
- Termination Date
- Jun 24, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 8544 bottles
Product description
Lisdexamfetamine Dimesylate Capsules, 40 mg, 100-count bottles, Rx Only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC 0527-4664-37
Reason for recall
Labeling: Label Mix-up. A bottle labeled as Lisdexamphetamine Dimesylate Capsules 40mg, contained Lisdexamphetamine Dimesylate Capsules 30mg.
Distribution pattern
Nationwide within the USA
Code information
Lot #: 25280726A, Exp. Date 03/2027
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0599-2025
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026